Philip Dubois - Sonic Healthcare Executive Director

SKHCF Stock  USD 17.01  0.01  0.06%   

Director

Dr. Philip J. Dubois is an Executive Director of Sonic Healthcare Limited. Dr Dubois is CEO of Sonics Imaging Division and Chairman of the Sonic Imaging Executive Committee. A neuroradiologist and nuclear imaging specialist, he is currently an Associate Professor of Radiology at the University of Queensland Medical School. He has served on numerous government and craft group bodies, including the councils of the Royal Australian and New Zealand College of Radiologists and the Australian Medical Association, and as VicePresident of the Australian Diagnostic Imaging Association. He is a nonexecutive Director of Magnetica Limited . since 2001.
Age 71
Tenure 23 years
Professional MarksPh.D
Phone61 2 9855 5444
Webhttps://www.sonichealthcare.com

Sonic Healthcare Management Efficiency

The company has return on total asset (ROA) of 0.1111 % which means that it generated a profit of $0.1111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2175 %, meaning that it generated $0.2175 on every $100 dollars invested by stockholders. Sonic Healthcare's management efficiency ratios could be used to measure how well Sonic Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 1.58 B in total debt with debt to equity ratio (D/E) of 0.41, which is about average as compared to similar companies. Sonic Healthcare has a current ratio of 1.09, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Sonic Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Sonic Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sonic Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sonic to invest in growth at high rates of return. When we think about Sonic Healthcare's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Roberto MendozaPrenetics Global
67
Ronald HuntNeuronetics
52
Yossi BahagonDarioHealth Corp
46
Jan HolsboerPrenetics Global
68
William HumphriesAclaris Therapeutics
51
Albert ChaAclaris Therapeutics
42
Kevin MeyersPrenetics Global
61
Andrew PowellAclaris Therapeutics
60
Charles ODataFonar
82
Debra PerryPrenetics Global
64
Glenn MuirNeuronetics
59
Brian GavinBurning Rock BiotechLtd
N/A
Kevin TwomeyPrenetics Global
67
Remy SautterPrenetics Global
69
Judith HanrattyPrenetics Global
71
Ori ZancoDarioHealth Corp
N/A
Michael ByronBurning Rock BiotechLtd
55
Cheryl BlanchardNeuronetics
53
Richard BierlyAclaris Therapeutics
60
Dennis McGrathDarioHealth Corp
60
Brian GibsonPrenetics Global
58
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia. SONIC HEALTHCARE operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 41000 people. Sonic Healthcare Limited [SKHCF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Sonic Healthcare Leadership Team

Elected by the shareholders, the Sonic Healthcare's board of directors comprises two types of representatives: Sonic Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sonic. The board's role is to monitor Sonic Healthcare's management team and ensure that shareholders' interests are well served. Sonic Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sonic Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Julian Adler, Chief Imaging
Mrs Schottdorf, Chief Group
Neville Mitchell, Non-Executive Independent Director
BEc CA, Deputy Sec
Louis Panaccio, Non-Executive Independent Director
Colin Goldschmidt, CEO, Managing Director, Investor Relations Contact Officer, Executive Director
Peter Savage, Chief Officer
Elizabeth Wilson, Independent Non-Executive Director
Philip Dubois, Executive Director
Kathryn Spargo, Non-Executive Independent Director
Stephen Fairy, Global Officer
Christopher Wilks, Finance Director, Executive Director
FAICD FRCPA, MD CEO
BCom FACID, CFO Director
David Byrne, Chief Laboratory
Prashan Kulasekera, Assistant Sec
Mark Compton, Non-Executive Independent Director
Paul Alexander, Company Secretary

Sonic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sonic Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonic Healthcare Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Sonic Healthcare information on this page should be used as a complementary analysis to other Sonic Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for Sonic Pink Sheet analysis

When running Sonic Healthcare's price analysis, check to measure Sonic Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonic Healthcare is operating at the current time. Most of Sonic Healthcare's value examination focuses on studying past and present price action to predict the probability of Sonic Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonic Healthcare's price. Additionally, you may evaluate how the addition of Sonic Healthcare to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Please note, there is a significant difference between Sonic Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonic Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonic Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.